Symposia: Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Autoimmune disorders, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, Combination therapy, AML, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Lymphomas, CLL, Non-Hodgkin lymphoma, Drug development, Translational Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Plasma Cell Disorders, B Cell lymphoma, Clinical Research, T Cell lymphoma, Pediatric, Supportive Care, Diseases, Immune Disorders, Immune mechanism, Cell expansion, Indolent lymphoma, Treatment Considerations, Biological therapies, Immunotherapy, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Infusion, Young adult , Biological Processes, Myeloid Malignancies, Emerging technologies, Technology and Procedures, Miscellaneous Cellular Therapies, Study Population, Human, Measurable Residual Disease
Type: Poster
Hematology Disease Topics & Pathways:
Research, Autoimmune disorders, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, Combination therapy, AML, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Lymphomas, CLL, Non-Hodgkin lymphoma, Drug development, Translational Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Plasma Cell Disorders, B Cell lymphoma, Clinical Research, T Cell lymphoma, Pediatric, Supportive Care, Diseases, Immune Disorders, Immune mechanism, Cell expansion, Indolent lymphoma, Treatment Considerations, Biological therapies, Immunotherapy, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Infusion, Young adult , Biological Processes, Myeloid Malignancies, Emerging technologies, Technology and Procedures, Miscellaneous Cellular Therapies, Study Population, Human, Measurable Residual Disease
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH